BioSpace News Archive

DaVita Kidney Care, a division of DaVita Inc. celebrates Robert Provenzano, M.D., FACP, FASN, for receiving the Distinguished Nephrology Service Award from the Renal Physicians Association (RPA) at its annual meeting last week in Orlando, Florida.

CytRx Corporation announced financial results for the year ended December 31, 2017, and provided an overview of recent accomplishments and upcoming milestones for its research and development programs.

WallStEquities.com is offering reports on AIMT, ATRA, AVXS, and AXSM.

WallStEquities.com is offering reports on BDX, EKSO, COO, and WAT.

The Company included data on modified leak test experiments, testing to confirm lack of fluid ingress occurring under the distal end cap of the devices, as well as real-world data from market research commissioned by TSO3 reflecting the actual use-life of duodenoscopes.

Expect U.S. regulatory submission for diabetic retinopathy later this year.

Researchers sought to identify a lead candidate for the treatment of Clostridium difficile (C. difficile) infections based on the lantibiotic Mutacin 1140.

ShangPharma Innovation Inc., a global venture capital firm focused on filling the critical investment gap that exists for the earliest-stage therapeutic breakthroughs, has expanded its life science incubator by nearly 40 percent and updated the facility with additional state-of-the-art laboratory infrastructure and conferencing space.

Proceeds to Support Advancement of Pipeline into Clinical Studies

Adults with obesity treated with semaglutide 0.4 mg administered once-daily via subcutaneous injections lost up to 13.8% of their body weight after 52 weeks in a phase 2 trial, significantly more than those treated with placebo who lost 2.3% of their body weight.